戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 east in some cases it resolves with residual hard exudate.
2 ated with increased risk of CSME and retinal hard exudate.
3 al pigment epithelium alterations with dense hard exudates.
4 e associated with the development of retinal hard exudates.
5 loss is likely to be associated with retinal hard exudate and serum lipid abnormalities.
6                                              Hard exudates and CME regressed completely in 15 of 15 a
7 id not show significant risk in worsening of hard exudates and severity of DME in the lipid-lowering
8 clinically significant macular edema (CSME), hard exudates, and other diabetic retinopathy (DR) end p
9                                              Hard exudate area was assessed from color fundus stereop
10 es from autopsy specimens have characterized hard exudates as a composition of lipid-laden macrophage
11 d exudate scores, and ETDRS scores minus the hard exudate component.
12 and triglycerides) with development of CSME, hard exudate, DR progression, and development of prolife
13 ological outcomes between eyes with baseline hard exudates (HE) and all other eyes among patients wit
14 inopathy Study protocol) for the presence of hard exudates (HE), retinal thickening (RT), clinically
15                                              Hard exudates (HEs) are the classical sign of diabetic r
16 ith higher risk of incident CSME and macular hard exudate in the DCCT cohort.
17  they were mild increase in CFT, presence of hard exudates in center subfield, and absence of renal d
18              However, the characteristics of hard exudates in living patients have not been examined
19              This differentiation of retinal hard exudates in patients by AO-SLO may help in understa
20 y (AO-SLO) to examine the characteristics of hard exudates in patients with retinal vascular diseases
21 acy of radially arranged sectors affected by hard exudates in the detection of CSME.
22 on-wool spots, intraretinal hemorrhages, and hard exudates in the macula were observed by ophthalmosc
23 bles morphological classification of retinal hard exudates into two types, which could not be disting
24                 Clinically, this appeared as hard exudate on funduscopic images.
25 than the thickness in regions with irregular hard exudates (P = 0.01 -->0.02).
26 tinal mass, and vitreous seeds resolved, the hard exudates persisted for more than 2 years after the
27                                              Hard exudates regressed completely in 14 of 15 eyes and
28 he macular edema had completely resolved and hard exudates regressed slowly in 100% of patients.
29  lipid-lowering group compared with placebo (hard exudates: relative risk, 1.00; 95% CI, 0.47-2.11; P
30 ed visual acuity (BCVA), presence of retinal hard exudates, retinal detachment (RD), cystoid macular
31 and RR 1.95, P for trend = 0.03 for LDL) and hard exudate (RR 2.44, P for trend = 0.0004 for total-to
32 t Diabetic Retinopathy Study (ETDRS) scores, hard exudate scores, and ETDRS scores minus the hard exu
33    Similarly, for the development of retinal hard exudates, the RR for the top vs bottom quintile of
34  The retinal thickness in regions with round hard exudates was significantly greater than the thickne
35                                      Retinal hard exudate, which is accompanied by macular edema, is
36                                 The cases of hard exudates within 1 disc diameter (DD) of the fovea (

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。